MID1
Basic information
Region (hg38): X:10445310-10833654
Links
Phenotypes
GenCC
Source:
- X-linked Opitz G/BBB syndrome (Strong), mode of inheritance: XL
- X-linked Opitz G/BBB syndrome (Definitive), mode of inheritance: XL
- X-linked Opitz G/BBB syndrome (Definitive), mode of inheritance: XL
- X-linked Opitz G/BBB syndrome (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Opitz GBBB syndrome, type I | XL | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Gastrointestinal; Genitourinary; Neurologic | 9354791; 11030761; 12833403; 15121778; 15558842; 16619207; 20301502; 20671548; 22407675 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (361 variants)
- Inborn_genetic_diseases (69 variants)
- X-linked_Opitz_G/BBB_syndrome (61 variants)
- not_specified (30 variants)
- MID1-related_disorder (21 variants)
- History_of_neurodevelopmental_disorder (1 variants)
- Corpus_callosum,_agenesis_of (1 variants)
- EBV-positive_nodal_T-_and_NK-cell_lymphoma (1 variants)
- B-cell_immunodeficiency,_distal_limb_anomalies,_and_urogenital_malformations (1 variants)
- Abnormal_facial_shape (1 variants)
- Low-set_ears (1 variants)
- Clinodactyly_of_the_5th_finger (1 variants)
- Dandy-Walker_syndrome (1 variants)
- Hypertelorism (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MID1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000381.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 136 | 27 | 165 | |||
missense | 110 | 25 | 156 | |||
nonsense | 14 | 21 | ||||
start loss | 0 | |||||
frameshift | 19 | 10 | 29 | |||
splice donor/acceptor (+/-2bp) | 11 | |||||
Total | 42 | 30 | 113 | 161 | 36 |
Highest pathogenic variant AF is 0.00000891846
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MID1 | protein_coding | protein_coding | ENST00000317552 | 9 | 438424 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.980 | 0.0203 | 125716 | 0 | 3 | 125719 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.92 | 152 | 293 | 0.519 | 0.0000252 | 4402 |
Missense in Polyphen | 37 | 116.77 | 0.31686 | 1732 | ||
Synonymous | -0.187 | 122 | 119 | 1.02 | 0.0000107 | 1298 |
Loss of Function | 3.81 | 2 | 20.7 | 0.0965 | 0.00000160 | 336 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000217 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000122 | 0.00000879 |
Middle Eastern | 0.000217 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Has E3 ubiquitin ligase activity towards IGBP1, promoting its monoubiquitination, which results in deprotection of the catalytic subunit of protein phosphatase PP2A, and its subsequent degradation by polyubiquitination. {ECO:0000269|PubMed:10400985, ECO:0000269|PubMed:11685209, ECO:0000269|PubMed:22613722}.;
- Disease
- DISEASE: Opitz GBBB syndrome 1 (GBBB1) [MIM:300000]: A congenital midline malformation syndrome characterized by hypertelorism, genital-urinary defects such as hypospadias in males and splayed labia in females, cleft lip/palate, laryngotracheoesophageal abnormalities, imperforate anus, developmental delay and congenital heart defects. {ECO:0000269|PubMed:11030761, ECO:0000269|PubMed:15558842, ECO:0000269|PubMed:9354791, ECO:0000269|PubMed:9718340}. Note=The disease is caused by mutations affecting the gene represented in this entry. MID1 mutations produce proteins with a decreased affinity for microtubules.;
- Pathway
- Ubiquitin mediated proteolysis - Homo sapiens (human);Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
(Consensus)
Recessive Scores
- pRec
- 0.290
Intolerance Scores
- loftool
- 0.448
- rvis_EVS
- -0.78
- rvis_percentile_EVS
- 12.77
Haploinsufficiency Scores
- pHI
- 0.177
- hipred
- Y
- hipred_score
- 0.746
- ghis
- 0.615
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.801
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mid1
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- microtubule cytoskeleton organization;negative regulation of microtubule depolymerization;pattern specification process;positive regulation of stress-activated MAPK cascade;protein localization to microtubule;interferon-gamma-mediated signaling pathway
- Cellular component
- spindle;cytosol;microtubule;microtubule associated complex;cytoplasmic microtubule
- Molecular function
- protein binding;microtubule binding;zinc ion binding;transferase activity;ubiquitin protein ligase binding;identical protein binding;protein homodimerization activity;protein heterodimerization activity;phosphoprotein binding